Your session is about to expire
← Back to Search
Face Recognition Training for Face Blindness
N/A
Recruiting
Led By Joseph DeGutis, Ph.D.
Research Sponsored by Boston VA Research Institute, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
History of a significant neurological disorder including hydrocephalus, stroke, moderate to severe traumatic brain injury (TBI), severe neuromuscular diseases, or severe hypoxia due to cardiac arrest
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)
Summary
This trial will test new training methods to improve face processing in people with developmental prosopagnosia. Subjects will be randomly assigned one of three treatments.
Who is the study for?
This trial is for adults aged 18-90 with lifelong difficulties in recognizing faces, impacting daily life. They must perform poorly on specific face recognition tests. Excluded are those with severe cognitive impairments, psychiatric disorders like schizophrenia or major depression, substance dependence, recent behavioral interventions, or significant neurological disorders.
What is being tested?
The study compares two experimental training programs designed to improve face processing abilities in people with developmental prosopagnosia against an active control group. Participants will be randomly assigned to one of three groups: perception training, memory training, or placebo control.
What are the potential side effects?
As this trial involves non-medical interventions (training programs), there are no direct medical side effects expected. However, participants may experience fatigue or frustration during the exercises.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a history of serious brain or nerve conditions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, within 2 weeks post-training (approximately 10 weeks after baseline), 12 weeks after training ends (approximately 22 weeks after baseline)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Cambridge Face Memory Test from baseline to post-training
Change in Face Perception from baseline to post-training
Secondary study objectives
Change in Eye processing ability from baseline to post-training
Change in Face Recollection from baseline to post-training
Change in Holistic processing from baseline to post-training
+2 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Memory TrainingExperimental Treatment1 Intervention
Participants will perform 6 weeks of face memory training (5 x 40 min sessions/week) that targets enhancing encoding to improve face recollection. As training progresses, the repetition lags (spaces between repeated foil faces) and number of faces will increase.
Group II: Perception TrainingActive Control1 Intervention
Participants will perform 6 weeks of face perception training (5 x 40 min sessions/week) that require discriminating faces based on internal features (e.g., eyebrow-eye distance). As training progresses, the faces will become more challenging and the face sizes will vary.
Group III: Active Control TrainingPlacebo Group1 Intervention
Participants will perform 6 weeks of face perception training (5 x 40 min sessions/week) that require discriminating faces based on external facial features (e.g., hair). As training progresses, the faces will become more challenging and the face sizes will vary.
Find a Location
Who is running the clinical trial?
Boston VA Research Institute, Inc.Lead Sponsor
23 Previous Clinical Trials
10,774 Total Patients Enrolled
Joseph DeGutis, Ph.D.Principal InvestigatorHarvard Medical School/VA Boston Healthcare Systems
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of serious brain or nerve conditions.You have serious mental health conditions like schizophrenia, major depression, bipolar disorder, or severe obsessive-compulsive disorder.You have had trouble recognizing faces for as long as you can remember, and it affects your daily life. This difficulty is not due to a specific event like a stroke or seizure.You are currently addicted to alcohol or drugs.You have performed significantly below average on tests that measure how well you recognize famous faces and remember faces.I had a mild head injury or simple concussion over 6 months ago and have had fewer than 5 concussions.You have been diagnosed with ADHD, and you have been taking the same medication for at least 6 months.I am between 18 and 90 years old.I have no impairments like poor hearing, vision, or muscle issues affecting my thinking.I am currently in, or was in the last 6 months, a treatment program for my behavior or using medication.
Research Study Groups:
This trial has the following groups:- Group 1: Memory Training
- Group 2: Perception Training
- Group 3: Active Control Training
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.